China Money Network
Login
Join

Fidelity Leads $97M Series C Round In Chinese Oncology Medicine Firm Antengene

  • July 20, 2020 — 14:25 CST

This Data Is Locked!

This area is available only to Subscribers.

Antengene, a Chinese clinical-stage therapeutics company focused on oncology, today announced the completion of a US$97 million series C round financing led by Fidelity Management... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: